Company / SG&A Expense
VOLITIONRX LTD SG&A Expense History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$8.5M
FY2025
5-year range
$5.7M / $11.7M
FY2021-FY2025
Trend
-18.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $247,405 in FY2012 to $12M in FY2022.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +12.4%.
Improved from $10M to $8M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2025, sg&a expense decreased 18.1% year-over-year.
- Peak sg&a expense was recorded in FY2022.
- Lowest sg&a expense in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.5M | -18.1% |
| FY2024 | $10.4M | +1.9% |
| FY2023 | $10.2M | -12.8% |
| FY2022 | $11.7M | +106.5% |
| FY2021 | $5.7M | +19.5% |
| FY2020 | $4.7M | -18.7% |
| FY2019 | $5.8M | +1241.2% |
| FY2014 | $434.0K | -3.1% |
| FY2013 | $448.0K | +81.1% |
| FY2012 | $247.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026